Gedeon Richter PLC (FRA:RIG2)

Market Cap	5.58B +17.5%
Revenue (ttm)	2.42B +8.3%
Net Income	604.82M -2.9%
EPS	3.31 -2.8%
Shares Out	n/a
PE Ratio	9.22
Forward PE	7.86
Dividend	1.26 (4.21%)
Ex-Dividend Date	Jun 3, 2025

Volume	n/a
Average Volume	862
Open	30.20
Previous Close	30.58
Day's Range	30.20 - 30.20
52-Week Range	22.94 - 32.24
Beta	n/a
RSI	51.39
Earnings Date	Apr 30, 2026

About Gedeon Richter

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic ...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 10,943
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RIG2

Financial Performance

In 2025, Gedeon Richter's revenue was 928.96 billion, an increase of 8.33% compared to the previous year's 857.55 billion. Earnings were 232.34 billion, a decrease of -2.89%.

Financial numbers in HUF